切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2019, Vol. 13 ›› Issue (03) : 252 -254. doi: 10.3877/cma.j.issn.1674-3903.2019.03.020

所属专题: 文献

综述

B细胞介导的体液免疫应答在肝移植急性排斥反应中的作用
周天保1,()   
  1. 1. 315010 宁波,中国科学院大学宁波华美医院医务部
  • 收稿日期:2019-05-20 出版日期:2019-08-25
  • 通信作者: 周天保
  • 基金资助:
    中国科学院大学宁波华美医院华美研究基金项目(2016HMKY22)

The role of humoral immune response mediated by B cells in the acute rejection after liver transplantation

Tianbao Zhou1,()   

  1. 1. Medical Department, Hwamei Hospital, University of Chinese Academy of Sciences, 315010 Ningbo, China
  • Received:2019-05-20 Published:2019-08-25
  • Corresponding author: Tianbao Zhou
  • About author:
    Corresponding author: Zhou Tianbao, Email:
引用本文:

周天保. B细胞介导的体液免疫应答在肝移植急性排斥反应中的作用[J/OL]. 中华移植杂志(电子版), 2019, 13(03): 252-254.

Tianbao Zhou. The role of humoral immune response mediated by B cells in the acute rejection after liver transplantation[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2019, 13(03): 252-254.

目前,国内外肝移植学界对肝移植术后急性排斥反应(AR)的机制阐释为T细胞介导的细胞免疫应答,但为获得长期生存仍需长期乃至终身服用免疫抑制剂。即使如此,临床上AR仍时有发生,并导致相当一部分受者移植肝功能丧失,更重要的是受者术后还受到感染、肿瘤和其他一系列不良反应及沉重经济负担的影响。因此,为肝移植AR机制提出新的理论解释,更全面深入阐明肝移植免疫排斥反应的内在机制,进而依据新的机制研制出新型免疫抑制剂已势在必行。本文就B细胞介导的体液免疫应答在肝移植AR中的作用作一综述。

The mechanism of acute rejection (AR) after liver transplantation is explained as T cells mediated cellular immune response at home and abroad, but in order to achieve long-term survival, it is still necessary to take immunosuppressants for a long time or even for life. Even so, AR still occurs from time to time in clinic, and leads to the loss of transplant liver function in a considerable number of recipients. More importantly, the recipients are also affected by infection, tumor and a series of other adverse reactions and heavy economic burden. Therefore, it is imperative to put forward a new theoretical explanation for the AR mechanism of liver transplantation, and to clarify the internal mechanism of immune rejection of liver transplantation more comprehensively and deeply, and then to develop new immunosuppressants according to the new mechanism. This article reviews the role of humoral immune response mediated by B cells in the AR after liver transplantation.

1
Starzl TE, Marchioro TL, Vonkaulla KN, et al. Homotransplantation of the liver in humans[J]. Surg Gynecol Obstet, 1963, 117: 659-676.
2
Briscoe DM, Sayegh MH. A rendezvous before rejection: where do T cells meet transplant antigens?[J]. Nat Med, 2002, 8(3): 220-222.
3
Qian S, Lu L, Fu F, et al. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction[J]. J Immunol, 1997, 158(10): 4654-4661.
4
Banff schema for grading liver allograft rejection:An international consensus document[J]. Hepatology, 1997, 25(3): 658-663.
5
Estrada CC, Maldonado A, Mallipattu SK. Therapeutic inhibition of VEGF signaling and associated nephrotoxicities[J]. J Am Soc Nephrol, 2019, 30(2): 187-200.
6
Cohen PA, Jhingran A, Oaknin A, et al. Cervical cancer[J]. Lancet, 2019, 393(10167): 169-182.
7
Smith RJ Jr, Yi T, Nasiri B, et al. Implantation of VEGF-functionalized cell-free vascular grafts: regenerative and immunological response[J]. FASEB J, 2019, 33(4): 5089-5100.
8
Zhou TB, Yang GS. Roles of vascular endothelial growth factor in acute rejection reaction following liver transplantation[J]. Transpl Immunol, 2011, 25(4): 207-209.
9
Zhang C, Yang G, Lu D, et al. Expression of vascular endothelial growth factor and basic fibroblast growth factor in acute rejection reaction following rat orthotopic liver transplantation[J]. Exp Ther Med, 2014, 8(2): 483-487.
10
周天保,陈规划,杨扬,等. 大鼠原位肝移植急性排斥反应模型的建立[J]. 中国实验动物学报,2009, 17(2): 120-124.
11
周天保,杨广顺. VEGF在大鼠原位肝移植急性排斥反应中的表达研究[J]. 中华普通外科杂志,2011, 26(10): 865-866.
12
Lin-Wang HT, Cipullo R, Dias Franca JI, et al. Intragraft vasculitis and gene expression analysis: Association with acute rejection and prediction of mortality in long-term heart transplantation[J]. Clin Transplant, 2018, 32(10): e13373.
13
Starling RC, Stehlik J, Baran DA, et al. Multicenter analysis of immune biomarkers and heart transplant outcomes: Results of the clinical trials in organ transplantation-05 Study[J]. Am J Transplant, 2016, 16(1): 121-136.
14
Berberat PO, Friess H, Schmied B, et al. Differentially expressed genes in postperfusion biopsies predict early graft dysfunction after liver transplantation[J]. Transplantation, 2006, 82(5): 699-704.
15
Geleff S, Draganovici D, Jaksch P, et al. The role of chemokine receptors in acute lung allograft rejection[J]. Eur Respir J, 2010, 35(1): 167-175.
16
Conti A, Scala S, D′Agostino P, et al. Wide gene expression profiling of ischemia-reperfusion injury in human liver transplantation[J]. Liver Transpl, 2007, 13(1): 99-113.
17
Yatoh S, Kawakami Y, Imai M, et al. Effect of a topically applied neutralizing antibody against vascular endothelial growth factor on corneal allograft rejection of rat[J]. Transplantation, 1998, 66(11): 1519-1524.
18
Galián JA, Mrowiec A, Muro M,et al. Molecular targets on B-cells to prevent and treat antibody-mediated rejection in organ transplantation. Present and future[J]. Expert Opin Ther Targets, 2016, 20(7): 859-867.
[1] 陈进宏. 腹腔镜活体供肝获取规范与创新[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 324-324.
[2] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会. 中国活体肝移植供者微创手术技术指南(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 241-252.
[3] 仲福顺, 余露, 范晓礼, 叶啟发. 肝移植治疗肝上皮样血管内皮瘤一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 293-297.
[4] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[5] 贺健, 张骊, 王洪海, 蒋文涛. 肝移植术后脾功能亢进转归及治疗研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 310-314.
[6] 胡宁宁, 赵延荣, 王栋, 王胜亮, 郭源. FMNL3与肝细胞癌肝移植受者预后的相关性研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 283-288.
[7] 王淑贤, 张良灏, 王利君, 张慧, 郭源, 许传屾, 李志强, 蔡金贞, 解曼, 饶伟. 成人肝移植围手术期严重心血管事件危险因素分析及预测模型研究[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 222-229.
[8] 张丽娜, 邢建坤, 张梁, 李云生, 王兢, 孙丽莹, 朱志军. 婴幼儿活体肝移植受者术中麻醉护理单中心经验[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 235-238.
[9] 黄建朋, 邹建强, 宗华. 肝移植术后腹壁疝诊治初步经验[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 471-473.
[10] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[11] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[12] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[13] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[14] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[15] 张红君, 郑博文, 廖梅, 任杰. 超声及超声造影在肝移植术后上腹部淋巴结良恶性鉴别诊断中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 562-567.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?